Is Ventas (VTR) overvalued or fairly valued?

MarketChacha shows Ventas's valuation in context — a trailing P/E of about 160.0, a forward P/E of about 107.0, a price-to-book of about 3.0 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

Does Ventas's reported profit turn into cash?

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash. MarketChacha computes this cash-conversion check (12.82×) from reported figures — education, not a rating.

What is Ventas's revenue?

Ventas reported revenue of $5.8B for FY2025, with net profit of $261.5M, per official filings.

What is the share price of Ventas (VTR)?

Ventas last traded at $86.41 (+2.2% on the day), as of 10/20/2026 — a delayed quote shown for education, not investment advice.

Ventas

VTR · NYSE · Real Estate · United States

Snapshot

TickerVTR

ExchangeNYSE

SectorReal Estate

IndustryREIT - Healthcare Facilities

CountryUnited States

Employees542

HeadquartersChicago, United States

Websitewww.ventasreit.com

Filings tracked17

About Ventas

Ventas, Inc. is an S&P 500 company enabling exceptional environments that benefit a large and growing aging population. With approximately 1,450 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company's growth is fueled by its more than 900 senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. Ventas aims to deliver outsized performance by leveraging its operational expertise, data-driven insights from its Ventas OITM platform, extensive relationships and strong financial position. The Ventas portfolio also includes outpatient medical buildings, research centers and healthcare facilities. Ventas, Inc. is based in Illinois, Chicago. Ventas, Inc. was incorporated in 1983 in Maryland.

Who owns it

Insiders0.5%
Institutions99.5%
Public & other0.0%

1,401 institutional holders

Ownership breakdown from public market data.

Top holders

Blackrock Inc.10.87%
JPMORGAN CHASE & CO8.52%
Vanguard Portfolio Management LLC8.31%
Vanguard Capital Management LLC6.19%
State Street Corporation5.95%
FMR, LLC5.12%
Geode Capital Management, LLC2.73%
Principal Financial Group, Inc.2.72%

Largest institutional holders — last updated 6/30/2026.

Forensic scorecard

Latest ROE of 2.1% is on the low side — the business earns a modest return on shareholder capital.

Cash conversion12.82×

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash.

Net margin trend-0.7% → 4.5%

Margin has expanded by about 5.2 points — the business is getting more profitable.

Return on equity2.1%

Latest ROE of 2.1% is on the low side — the business earns a modest return on shareholder capital.

Computed by MarketChacha from reported figures (SEC XBRL). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev $1.8B · EPS 0.13

Est. earnings growth +5.1%

Next fiscal year

Rev $7.9B · EPS 0.79

Est. earnings growth +79.6%

Analyst consensus estimates — not the company's own guidance.

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: SEC XBRL

Annual

Quarterly · last 8

Revenue (FY2025)

$5.8B

Net margin

4.5%

ROE

2.1%

Revenue CAGR (2y)

+13.9%

EPS (FY2025)

0.54

Net profit (FY2025)

$261.5M

Ask MarketChacha about VTR

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin	ROE
FY2025	$5.8B	$261.5M	0.54	4.5%	2.1%
FY2024	$4.9B	$88.4M	0.19	1.8%	0.8%
FY2023	$4.5B	$-30.3M	-0.10	-0.7%	-0.3%

Quarterly

Period	Revenue	Net profit	EPS	Net margin
2026Q2	$1.7B	$72.2M	0.14	4.2%
2026Q1	$1.7B	$59.0M	0.11	3.6%
2025Q3	$1.5B	$68.7M	0.14	4.6%
2025Q2	$1.4B	$71.5M	0.15	5.0%
2025Q1	$1.4B	$48.4M	0.10	3.6%
2024Q3	$1.2B	$21.0M	0.05	1.7%
2024Q2	$1.2B	$21.2M	0.05	1.8%
2024Q1	$1.2B	$-12.5M	-0.04	-1.0%
2023Q3	$1.1B	$-69.6M	-0.18	-6.0%
2023Q2	$1.1B	$105.1M	0.26	9.5%
2023Q1	$1.1B	$18.9M	0.04	1.8%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2026

10-Q filing
SEC7/30/2026
8-K — Results of operations, Exhibits
SEC7/29/2026material
8-K — Executive/director change, Other events
SEC6/15/2026material
8-K — Executive/director change, Shareholder vote results, Other events, Exhibits
SEC5/15/2026material
10-Q filing
SEC4/28/2026
8-K — Results of operations, Exhibits
SEC4/27/2026material
8-K — Executive/director change
SEC2/20/2026material
8-K — Other events, Exhibits
SEC2/9/2026material
10-K filing
SEC2/6/2026
8-K — Results of operations, Exhibits
SEC2/5/2026material
8-K — Material agreement, Material financial obligation, Exhibits
SEC1/7/2026material

2025

8-K — Other events, Exhibits
SEC12/4/2025material
8-K — Executive/director change, Exhibits
SEC11/17/2025material
10-Q filing
SEC10/30/2025
8-K — Results of operations, Exhibits
SEC10/29/2025material
10-Q filing
SEC7/31/2025
8-K — Results of operations, Exhibits
SEC7/30/2025material

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.